BRIEF — Lonza Upgrades Organic Growth Model And Mid — Term Financial Ambitions At Capital Markets Day

Oct 14 (Reuters) — LONZA GROUP AG: Upgrades Organic Growth Model And Mid-term Financial Ambitions At Capital Markets Day; Q3 2026 In Line With Expectations Model Targets 10-13% Organic Cer Sales Growth And Core Ebitda Margin In High Thirties Mid-term Confirms Upgraded Full-year 2026 Outlook Expects Negative Fx Impact Of 2% To 3% On 2026 Sales Growth Expects Mid-single-digit Cer Sales Growth And Core Ebitda Margin Expansion In Capsules & Health Ingredients For 2026 Reiterates Full-year 2026 Outlook Of 11—12% Cer Sales Growth And Core Ebitda Margin Of 33—34% Lonza Upgrades Its Organic Growth Model Of Low-teens Organic Cer Sales Growth On Average Over Time With An Acceleration Of Core Ebitda Margin Expansion, Now Reaching High Thirties In Mid-term It Also Expands Model To Include A Mid-term Roic Ambition Of Two To Three Times Today's Wacc And An Improving Fcf Conversion On Average Over Time, Reflecting Its Disciplined Investment Approach And Overall Greater Capital Efficiency Unchanged, Organic Capex Is Expected To Fluctuate Around Mid-to-high Teens Percentage Of Sales, While Lonza Remains Committed To A Progressive Dividend Distribution, All In Line With Its Capital Allocation Framew